INFLUENCE OF MAFLD ON LONG-TERM OUTMES AFTER VIRAL ERADICATION IN HCV-RELATED CIRRHOSIS WITH PORTAL HYPERTENSION

被引:0
|
作者
Alvarado-Tapias, Edilmar [1 ]
Lens, Sabela [2 ]
Semmler, Georg [3 ]
Brujats, Anna [4 ]
Abadia, Marta [5 ]
Llop, Elba [6 ]
Samaniego, Luis Ibanez [7 ]
Diez, Cristina [8 ]
Tellez, Luis [9 ]
Hartl, Lukas [3 ]
Puente, Angela [10 ]
Aznar, Anna Baiges [11 ]
Balcar, Lorenz [3 ]
Moya, Adolfo Gallego [1 ]
Oliveira, Antonio [12 ]
Calleja, Jose Luis [13 ]
Banares, Rafael [14 ]
Perez-Latorre, Leire [8 ]
Albillos, Agustin [15 ]
Fortea, Jose Ignacio [16 ]
Colell, Xavier Torras [1 ]
Reiberger, Thomas [17 ]
Garcia-Pagan, Juan Carlos [11 ]
Mandorfer, Mattias [18 ]
Forns, Xavier [2 ]
Sanchez, Candido Villanueva [1 ]
机构
[1] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[2] Hosp Clin Barcelona, Idibaps, Barcelona, Spain
[3] Med Univ Vienna, Dept Med 3, Div Gastroenterol & Hepatol, Vienna, Austria
[4] Hosp Santa Creu & Sant Pau, Madrid, Spain
[5] Hosp La Paz, Madrid, Spain
[6] Univ Autonoma Madrid, Madrid, Spain
[7] Gregorio Maranon Univ Hosp, Madrid, Spain
[8] Hosp Gen Univ Gregorio Maranon, Unidad Enfermedades Infecciosas VIH, Madrid, Spain
[9] Hosp Ramon & Cajal, Madrid, Spain
[10] Marques De Valdecilla Univ Hosp, Santander, Spain
[11] Hosp Clin Barcelona, Barcelona, Spain
[12] Hosp Univ La Paz, Dept Gastroenterol & Hepatol, Madrid, Spain
[13] Puerta Del Hierro Univ Hosp, Madrid, Spain
[14] Univ Complutense Madrid, Fac Med, Madrid, Spain
[15] Ramon y Cajal Inst Hlth Res, Madrid, Spain
[16] Hosp Marques De Valdecillas, Santander, Spain
[17] Austrian Acad Sci, Cemm Res Ctr Mol Med, Vienna, Austria
[18] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
3081-A
引用
收藏
页码:S1393 / S1395
页数:3
相关论文
共 50 条
  • [11] Spontaneous clearance of serum HCV-RNA after splenectomy in a patient with HCV-related liver cirrhosis and portal hypertension: a case report
    Ogata, Toshiro
    Sakai, Terufumi
    Shibata, Sho
    Kanno, Hiroki
    Nakane, Hiroyuki
    Aoyagi, Takeshi
    Koikawa, Kazuhiro
    Sadakari, Yoshihiko
    Hirokata, Gentaro
    Taniguchi, Masahiko
    SURGICAL CASE REPORTS, 2024, 10 (01)
  • [12] Impact of HCV eradication on recurrence pattern and long-term outcomes in patients with HCV-related hepatocellular carcinoma undergoing radiofrequency ablation
    Wu, Kuo-Cheng
    Lee, I-Cheng
    Chi, Chen-Ta
    Liu, Chien-An
    Chiu, Nai-Chi
    Hsu, Shao-Jung
    Lee, Pei-Chang
    Wu, Chi-Jung
    Luo, Jiing-Chyuan
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (07) : 940 - 952
  • [13] Measurement of Spleen Stiffness to Evaluate Portal Hypertension and the Presence of Esophageal Varices in Patients With HCV-Related Cirrhosis
    Colecchia, Antonio
    Montrone, Lucia
    Scaioli, Eleonora
    Bacchi-Reggiani, Maria Letizia
    Colli, Agostino
    Casazza, Giovanni
    Schiumerini, Ramona
    Turco, Laura
    Di Biase, Anna Rita
    Mazzella, Giuseppe
    Marzi, Luca
    Arena, Umberto
    Pinzani, Massimo
    Festi, Davide
    GASTROENTEROLOGY, 2012, 143 (03) : 646 - 654
  • [14] LONG-TERM OUTCOME OF HCV-RELATED MIXED CRYOGLOBULINEMIA IN PATIENTS ACHIEVING SUSTAINED VIRAL RESPONSE (SVR) AFTER ANTIVIRAL THERAPY
    Petrarca, A.
    Razzolini, G.
    Monti, M.
    Giannini, C.
    Caini, P.
    Piluso, A.
    Gragnani, L.
    Ranieri, J.
    Fognani, E.
    Moneglia, M.
    Laffi, G.
    Zignego, A. L.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S45 - S45
  • [15] Letter: 'Impact of HCV Eradication on Recurrence Pattern and Long-Term Outcomes in Patients With HCV-Related Hepatocellular Carcinoma Undergoing Radiofrequency Ablation'
    Xu, You-Jian
    Pang, Hui-Ming
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (01) : 230 - 231
  • [16] Long-term results of interferon therapy after hepatectomy for patients with HCV-related hepatocellular carcinoma
    Saito, A
    Haruyama, K
    Nozawa, H
    Chiba, M
    Shiratori, K
    Katagiri, S
    Katsuragawa, H
    Yamamoto, M
    Takasaki, K
    JOURNAL OF HEPATOLOGY, 2005, 42 : 99 - 100
  • [17] Pathophysiology of portal hypertension in HCV-related cirrhosis - Putative role of assessment of portal pressure gradient in Peginterferon-treated patients
    Ratti, L
    Pozzi, M
    Bosch, J
    DIGESTIVE AND LIVER DISEASE, 2005, 37 (11) : 886 - 893
  • [18] Long-term results after PUT for HCV-related small HCC and its prognostic factors
    Ryoko, K
    Masatoshi, T
    Eiji, A
    Riko, H
    Ryukichi, K
    Michio, S
    ASIAN PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER MEETING 2002, 2002, : 149 - 151
  • [19] Blood microbiome is associated with changes in portal hypertension after successful direct-acting antiviral therapy in patients with HCV-related cirrhosis
    Virseda-Berdices, Ana
    Brochado-Kith, Oscar
    Diez, Cristina
    Hontanon, Victor
    Berenguer, Juan
    Gonzalez-Garcia, Juan
    Rojo, David
    Fernandez-Rodriguez, Amanda
    Ibanez-Samaniego, Luis
    Llop-Herrera, Elba
    Olveira, Antonio
    Perez-Latorre, Leire
    Barbas, Coral
    Rava, Marta
    Resino, Salvador
    Jimenez-Sousa, Maria Angeles
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (03) : 719 - 726
  • [20] The Effect of Splenectomy and Subsequent Interferon Therapy in Patients With HCV-Related Liver Cirrhosis in the Long Term
    Inagaki, Yuji
    Yamamoto, Norihiko
    Shiraki, Katsuya
    Yada, Takazumi
    Yoshizawa, Naohiko
    Beppu, Tetsuya
    Sugimoto, Kazushi
    Ogura, Suguru
    Tameda, Masahiko
    Kusagawa, Satoko
    Nojiri, Keiichiro
    Takei, Yoshiyuki
    Sakurai, Hiroyuki
    Isaji, Shuji
    GASTROENTEROLOGY, 2013, 144 (05) : S984 - S984